Fendx Technologies, Inc. · CSE:FNDX
Fendx Technologies — Investor Presentation (October 2023)
22 slides from Fendx Technologies's investor presentation, October 2023
Slide 1: Making Lives Safer Through Nanotechnology
Making Lives Safer Through NANOTECHNOLOGY P R E V E N T I N G T H E S P R E A D O F PAT H O G E N S CSE: FNDX | OTCQB: FDXTF | FSE: E8D / I N V E S T O R P R E S E N TAT I O N / OCTOBER 2023 CSE: FNDX | OTCQB: FDXTF | FSE:E8D Investor Presentation – October 2023 / 1
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface and coating
Slide 3: FendX is a nanotechnology company reducing the spread of pathogens
FendX is a nanotechnology >99% company focused on Film: Instant reduction of adhesion of Covid-19 reducing the spread of like virus1 pathogens to keep surfaces safe from contamination. >99% Spray: Instant reduction Film nanotechnology has repelling properties that of adhesion of Covid-19 prevent adh
Slide 4: Our Nanotechnology in the Media
Our Nanotechnology in the Media “Researchers have developed a self-cleaning plastic wrap that repels bacteria and could be “The ultimate non-stick coating.” used to prevent the transfer of antibiotic - McMaster University Brighter World resistant superbugs, and other forms of Read more dangerous bac
Slide 5: Investment Highlights
Investment Highlights A N T I M I C R O B I A L C O AT I N G M A R K E T E S T I M AT E D T O R E A C H $ 7 . 6 B I L L I O N B Y 2 0 2 5 1 Unique Disruptive Technology Global Need for Innovative Products to • Award-winning nanotechnology with instant repelling Combat the Spread of Pathogens and Vir
Slide 6: Effective Pathogen Control Requires Innovative Solutions
Effective Pathogen Control Requires Innovative Solutions THE PROBLEM • Infections continue to be responsible for high morbidity and mortality rates1 • Global health protection agencies seeking innovative solutions to reduce the spread of life-threatening pathogens • > 99,000 of deaths annually in U.
Slide 7: Surfaces and Objects Can Spread Pathogens
Surfaces and Objects Can Spread Pathogens PAT H O G E N S E X I S T I N C R I T I C A L A N D E V E R Y D AY E N V I R O N M E N T S O N H I G H - TO U C H S U R FAC E S HEALTHCARE TRANSPORTATION SPORTS & SCHOOLS OFFICES ENVIRONMENTS ENTERTAINMENT DOORKNOBS, HANDRAILS & MORE ELEVATOR PANELS & BUTTON
Slide 8: REPELWRAP Film
REPELWRAP™ Film First product in development to protect against contamination on surfaces Award-winning REPELWRAPTM film instantly repels bacteria, viruses, blood and liquids. Dunmore International Corp. (“Dunmore”), a Untreated Surface* Treated Steel Partners Holdings L.P. (NYSE:SPLP) Surface* oper
Slide 9: REPELWRAP Film, a Patented Innovation
REPELWRAP™ Film, a Patented Innovation Our patent-pending nanotechnology works by combining micro- and nano-layers and thermal shrinking to create surfaces with repelling properties that prevent the adhesion of bacteria, viruses and liquids. High-surface tension (e.g., water) and low-surface tension
Slide 10: REPELWRAP Film Proven to Prevent the Spread of Pathogens
REPELWRAP™ Film Proven to EFFECTIVENESS Prevent the Spread of Pathogens >99% Reduction in adhesion of Covid-19 like strains1 DURABILITY Holds repelling properties under strain and >87% Reduction in colony formation of MRSA2 while conforming to different form factors (bent or unbent)2 Surface remains
Slide 11: How Our Nano-Surfaces Work
Coated with Nanotechnology How Our Nano-Surfaces Work When a contaminated hand touches a surface covered with our nanotechnology, the contamination stays on the hand and does not transfer to the surface. Uncoated Schematic illustration comparing person-to-person transfer of viruses from common high
Slide 12: Competitive Landscape: Film and Spray Nanotechnology
Competitive Landscape: Film and Spray Nanotechnology Metal- FendX Film FendX Spray Liquid Containing** and Nanotechnology* Nanotechnology* Disinfectants Photo-Activated Films Surface repels bacteria, viruses, blood and +++ +++ - - liquids Kills bacteria and viruses - +++ +++ +++ Effective pathogen c
Slide 13: Antimicrobial Coating Market: A Significant Opportunity
Antimicrobial Coating Market: A Significant Opportunity for Our Nanotechnology G l o b a l a n t i m i c r o b i a l c o a t i n g m a r k e t e s t i m a t e d t o r e a c h $ 7 . 6 b i l l i o n i n 2 0 2 5 1. Medical and healthcare is the largest segment of the Total Global Revenues for Antimicro
Slide 14: Pipeline & Growth Strategy
Pipeline & Growth Strategy • Line extensions of REPELWRAPTM film ORGANIC • Further development of core technology into GROWTH additional applications (i.e., catheters) • Development of spray nanotechnology Assess opportunities for the following: • Assess applications for our nanotechnology GROWTH be
Slide 15: Catheter Product Development – The Next Opportunity
Catheter Product Development – The Next Opportunity • Will be commencing a development program to coat Failure of long-term indwelling catheters is medical catheters with FendX’s nanotechnology commonly caused by blood clots and/or • In early research, McMaster has shown coating bacterial biofilm fo
Slide 16: Expanded Nanotechnology Platform with a Spray Formulation
Expanded Nanotechnology Platform with a Spray Formulation that Repels and Kills Bacteria and Viruses Development-stage nano-spray coating • Reduced adhesion of MRSA by 99.9% and 98% for Phi6 An important addition to our (Covid-19 like virus)1 current nanotechnology as it could be easier to apply to
Slide 17: Key Achievements and Objectives
Key Achievements and Objectives SIGNED DEVELOPMENT AGREEMENT WITH COMPLETE MANUFACTURER DUNMORE REPELWRAP™ INTERNATIONAL CORP. FILM COMMERCIAL COMMENCE SCALE-UP INTERMEDIATE SCALE-UP AND LAUNCH TESTING OF REPELWRAP™ FILM REPELWRAP™ IN CANADA FILM COMMENCE COMPLETE LISTED ON DTC REPELWRAP™ FILM COATE
Slide 18: Efficient Operating Model
Efficient Operating Model C O S T- E F F E C T I V E S T R AT E G Y T O M A N U FA C T U R E A N D S E L L F E N D X PRODUCTS Intention to leverage the expertise of contract manufacturers and distributor to efficiently manage FendX capital expenditures Manufacturers Sales Distributors Establish part
Slide 19: Proven Team Management
Proven Team Management Dr. Carolyn Myers MBA, PhD Andrea Mulder BPHE, MBA Rose Zanic CPA, CA President, CEO & Director COO CFO & Corporate Secretary • Principal of BioEnsemble LLC, assisting • Over 25 years of pharma/biotech • Over 25 years of capital markets and start-ups and small pharma companies
Slide 20: Board of Directors
Board of Directors Dr. Carolyn Myers MBA, PhD Stephen Randall CPA, CGA Pierre Soulard B.C.L., LLB, LLM President, CEO & Director Independent Board Member Independent Board Member & Audit Committee Chair • Principal of BioEnsemble LLC, assisting • Chief Legal Officer of CoinSmart (NEO: start-ups and
Slide 21: Share Structure
Share Structure CSE: FNDX / AS OF SEPTEMBER 30, 2023 Common Stock 52,991,606 Stock Options 2,741,667 Warrants 15,905,807 Bonus Shares1 4,150,000 Fully-Diluted 75,789,080 1 Shares issuable upon satisfaction of certain development milestones. CSE: FNDX | OTCQB: FDXTF | FSE:E8D Investor Presentation –
Slide 22: Thank You!
THANK YOU! Reach out to us with any questions. investor@fendxtech.com / fendxtech.com CSE: FNDX | OTCQB: FDXTF | FSE:E8D Investor Presentation – October 2023 / 22
FendX Technologies — Investor Presentation (October 2023) on 6ix